Clinical Blood Flow Measurement with [15O] Water and Positron Emission Tomography (PET)

  • Hichwa R
  • Ponto L
  • Watkins G
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

[15O]-labeled water has been used to measure brain blood flow for many years (Herscovitch, et al. 1983). While now considered a common procedure, it remains difficult to consistently perform quantitative PET blood flow measurements at most institutions. Blood flow as measured with [15O] H2O remains the only technique, in the majority of clinical PET centers, that can be performed very quickly and repeatedly to assess the cognitive state of a patient or research subject. The most widely used PET radiopharmaceutical, 2-[18F]fluoro-2-deoxy-D-glucose ([18F] FDG) clearly shows metabolic function of brain, heart or tumor. However, its long half-life (110 min) precludes performing repeat studies on the same day. Only one temporal assessment of function with [18F] FDG can be obtained when the patient is at the PET Center. The short half-life of [15O] (122 sec) permits multiple assessments to occur especially if intervention is planned (drug or cognitive activation). [15O] water can easily be produced on demand within a short time without significant radiochemistry involvement. Blood flow to other organs and tissues (bone marrow, heart or tumor) is also possible and is routinely performed at this institution.

Cite

CITATION STYLE

APA

Hichwa, R. D., Ponto, L. L. B., & Watkins, G. L. (1995). Clinical Blood Flow Measurement with [15O] Water and Positron Emission Tomography (PET). In Chemists’ Views of Imaging Centers (pp. 401–417). Springer US. https://doi.org/10.1007/978-1-4757-9670-4_44

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free